RecruitingNot ApplicableNCT06974838

Explore the Therapeutic Effect of Theta Burst Stimulation on Emotion Regulation in Autism With Minimally Verbal Ability or Intellectual Disability


Sponsor

Chang Gung Memorial Hospital

Enrollment

60 participants

Start Date

Aug 8, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The investigator would like to investigate the impact of theta-burst stimulation over left DLPFC in autism with minimally verbal ability or intellectual disability


Eligibility

Min Age: 8 YearsMax Age: 30 Years

Inclusion Criteria2

  • Diagnosis of autism spectrum disorder, confirmed by DSM-5.
  • Individuals with minimal verbal ability or intellectual disability (FSIQ < 70).

Exclusion Criteria15

  • Current or past severe neurological disorders, such as epilepsy, or significant visual or hearing impairments.
  • Current or past severe systemic diseases, such as cardiovascular disease, diabetes, or multiple sclerosis.
  • History of severe brain injury.
  • Presence of implanted metal devices, such as a pacemaker or medication pump.
  • Current or past severe psychiatric disorders, such as schizophrenia, bipolar disorder, or major depressive disorder.
  • Pregnancy.
  • Significant brain abnormalities, such as intracranial space-occupying lesions.
  • Family history of epilepsy.
  • History of febrile seizures.
  • Concurrent use of medications that increase the risk of seizures.
  • Sleep disorders during rTMS procedures.
  • Skin lesions or trauma at the stimulation site.
  • Deemed ineligible by the principal investigator (PI).
  • Participation in another clinical trial within the past month.
  • Suicidal ideation or suicide attempts within the past year.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEintermittent theta burst stimulation

stimulatory protocol


Locations(1)

Chang Gung Memorial Hospital

Taoyuan, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06974838


Related Trials